These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 10417432

  • 1. [Advanced breast cancer: an evaluation of the cost of recurrence].
    Bercez C, Lebrun T, Bonneterre ME, Selke B, Lenne X, Bonneterre J.
    Bull Cancer; 1999 Jun; 86(6):585-90. PubMed ID: 10417432
    [Abstract] [Full Text] [Related]

  • 2. [Cost effectiveness evaluation of breast cancer therapy. Comparative analysis 1975-1985 in a cancer prevention center].
    Lapeyre-Mestre M, Daly-Schveitzer N, Boussin G, Delande G.
    Rev Epidemiol Sante Publique; 1993 Jun; 41(5):397-406. PubMed ID: 8284480
    [Abstract] [Full Text] [Related]

  • 3. [Follow-up of patients with colorectal cancer resected for cure in the Herault area. A medico-economical study].
    Borie F, Daurès JP, Millat B, Folschveiller-Bruggeman M, Trétarre B.
    Gastroenterol Clin Biol; 2001 Oct; 25(10):881-4. PubMed ID: 11852391
    [Abstract] [Full Text] [Related]

  • 4. Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data.
    Lamerato L, Havstad S, Gandhi S, Jones D, Nathanson D.
    Cancer; 2006 May 01; 106(9):1875-82. PubMed ID: 16572409
    [Abstract] [Full Text] [Related]

  • 5. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
    Alexandrescu DT.
    Dermatol Online J; 2009 Nov 15; 15(11):1. PubMed ID: 19951637
    [Abstract] [Full Text] [Related]

  • 6. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H, Vicini FA, Kestin LL, Goldstein NS, Decker D, Pettinga J, Ingold J, Benitez P, Neumann K, Rebner M, Dekhne N, Martinez A.
    Cancer; 2004 Aug 15; 101(4):713-20. PubMed ID: 15305400
    [Abstract] [Full Text] [Related]

  • 7. [Adjuvant treatment of cancer of the breast: cost assessment of the protocol used].
    Selke B, Bercez C, Lenne X, Bonneterre ME, Lebrun T, Bonneterre J.
    Bull Cancer; 1998 Nov 15; 85(11):961-6. PubMed ID: 9951423
    [Abstract] [Full Text] [Related]

  • 8. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J, Kruszewski WJ, Sliwińska M, Kruszewska E, Hajdukiewicz W, Sliwiński W, Rolka-Stempniewicz G, Góralczyk M, Leśniewski-Kmak K.
    Przegl Lek; 2001 Nov 15; 58(6):498-503. PubMed ID: 11816740
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR.
    Cancer; 2007 Feb 01; 109(3):518-27. PubMed ID: 17186528
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
    Lê MG, Arriagada R, Spielmann M, Guinebretière JM, Rochard F.
    Cancer; 2002 Jun 01; 94(11):2813-20. PubMed ID: 12115367
    [Abstract] [Full Text] [Related]

  • 12. Partial breast irradiation as second conservative treatment for local breast cancer recurrence.
    Hannoun-Levi JM, Houvenaeghel G, Ellis S, Teissier E, Alzieu C, Lallement M, Cowen D.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1385-92. PubMed ID: 15590169
    [Abstract] [Full Text] [Related]

  • 13. Resource use and costs associated with different states of breast cancer.
    Lidgren M, Wilking N, Jönsson B, Rehnberg C.
    Int J Technol Assess Health Care; 2007 Dec 01; 23(2):223-31. PubMed ID: 17493308
    [Abstract] [Full Text] [Related]

  • 14. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
    Danish Breast Cancer Cooperative GroupDepartment of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus C, Denmark. hmn@oncology.dk, Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J.
    J Clin Oncol; 2006 May 20; 24(15):2268-75. PubMed ID: 16618947
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE, Karnon J, Smith RE, Johnston SR, Brandman J, Sung JC, Gross PE.
    Am J Manag Care; 2006 Jul 20; 12(7):374-86. PubMed ID: 16834524
    [Abstract] [Full Text] [Related]

  • 16. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA.
    Laryngoscope; 2001 Jun 20; 111(6):1079-87. PubMed ID: 11404625
    [Abstract] [Full Text] [Related]

  • 17. [Cost of treatment and follow up of breast cancer: a retrospective assessment in a comprehensive cancer centre].
    Lilliu H, Stevens D, Brun C, Morel J, Pen CL, Bonastre J, Bachelot F, Davesne C, Gentile A, Hirlimann E, Sabourin JC, Berlie J, Rouëssé J.
    Bull Cancer; 2002 Jun 20; 89(6):635-42. PubMed ID: 12135864
    [Abstract] [Full Text] [Related]

  • 18. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.
    Breast Cancer Res Treat; 2008 Jun 20; 109(3):405-16. PubMed ID: 17687650
    [Abstract] [Full Text] [Related]

  • 19. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J, Piotrowski T.
    Neoplasma; 2002 Jun 20; 49(6):426-31. PubMed ID: 12584593
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM, Shim B, Goodman S, Amonkar MM.
    Breast Cancer Res Treat; 2008 Mar 20; 108(2):297-305. PubMed ID: 17577662
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.